EP1879553
OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR AGONISTS HAVING ENHANCED ANTERIOR CLEARANCE RATES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.5.2006EP published:
12.2.2020EP application number:
06752463.7
EPO information:
European Patent Register
Max expiry date:
8.5.2026
Title:
OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR AGONISTS HAVING ENHANCED ANTERIOR CLEARANCE RATES
Timeline
Today
9.5.2006EP application
12.2.2020EP Publication
Owner
Name:
ALLERGAN, INC.Address:
2525 Dupont Drive, Irvine, CA 92612, US
Inventor
Name:
HUGHES, Patric, M.Address:
Aliso Viejo, CA 92656, US
Name:
BURKE, James, A.Address:
Santa Ana, CA 92705, US
Name:
CHANG-LIN, Joan-EnAddress:
Tustin, CA 92782, US
Priority
Number:
679771 PDate:
10.5.2005Country:
US
Classification
Categories:
A61K 9/10, A61K 31/498, A61K 9/16